Evidence Library
Filter by drug, type, year, and open access.
Showing 1–5 of 5 results
- Sustained-release naltrexone for opioid dependence — Cochrane Database of Systematic Reviews (2025)• Drug: naltrexone-extended-releaseDOIPMID
- TIP 63: Medications for Opioid Use Disorder — SAMHSA (2021)• Drug: naltrexone-extended-releaseOpen access
- The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update — Journal of Addiction Medicine (2020)• Drug: naltrexone-extended-releaseDOIPMID
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial — The Lancet (2018)• Drug: naltrexone-extended-releaseOpen accessDOIPMIDPMCID
- Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial — The Lancet (2011)• Drug: naltrexone-extended-releaseDOIPMID